FindTrial
Sign In

Clinical Study on Anti-JK3 Antibody Induced by Multiple Plasma Transfusions-related Immunity

Clinical Study on Anti-JK3 Antibody Induced by Multiple Plasma Transfusions-related Immunity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119180
Enrollment
Unknown
Registered
2026-02-24
Start date
2026-02-25
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Observation group:None

Sponsors

Fifth Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Received medical treatment at the Fifth Affiliated Hospital of Sun Yat-sen University from January 1, 2022 to July 31, 2025. 2.Anti-Jk3 antibody was detected in the patient by antibody identification. 3.Negative preliminary screening, urea lysis test.

Exclusion criteria

Exclusion criteria: 1.The patient with a negative result for anti-Jk3 antibody in antibody identification testing. 2.Patients with a positive result in the preliminary screening of the urea lysis test. 3.Patients with incomplete documentation of clinical examination data.

Design outcomes

Primary

MeasureTime frame
Serological characteristics;Genetic characteristics;—

Countries

China

Contacts

Public ContactYang Bin

Fifth Affiliated Hospital, Sun Yat-Sen University

zdwy2003@163.com+86 756 252 8347

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026